Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 18-Apr-2014
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 15)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
17-Apr-14S&P Capital IQ Quantitative ReportN/ASynthetic Biologics11$126.50  View Abstract
17-Apr-14Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - SYNTHETIC BIOLOGICS INCORPORATED (SYN-A)11$25  View Abstract
17-Apr-14ValuEngine, Inc.N/AValuEngine - Toronto Quantitative Stock Report for AEN11$25  View Abstract
17-Apr-14ValuEngine, Inc.N/AValuEngine Industry Report for OIL & Gas-cdn EXP & Prod17$49  View Abstract
17-Apr-14ValuEngine, Inc.N/AValuEngine Industry Report for Medical-biomed/genetics18$49  View Abstract
11-Apr-14Reuters Investment ProfileN/ASynthetic Biologics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138  View Abstract
11-Apr-14Zacks Investment Research Inc.N/ASYNTHETIC BIOLG (SYN) Zacks Company Snapshot1$11.50  View Abstract
11-Apr-14Ford Investor Services, Inc.N/AValue Graph: SYNTHETIC BIOLOG -- SYN1$11.50  View Abstract
11-Apr-14Ford Investor Services, Inc.N/AIndustry Value Graph: BONE , MNKD , MDVN , OPK , SYN -- DRUGS3$34.50  View Abstract
10-Apr-14Streetwise ReportsKeith MarkeyDon't Miss the Boat on Big Biotech Catalysts: Keith Markey9$92  View Abstract
Next 5

Independent Reports (Showing 1 to 10 of 15)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
17-Apr-14S&P Capital IQ Quantitative ReportN/ASynthetic Biologics11$126.50View Abstract
17-Apr-14Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - SYNTHETIC BIOLOGICS INCORPORATED (SYN-A)11$25View Abstract
17-Apr-14ValuEngine, Inc.N/AValuEngine - Toronto Quantitative Stock Report for AEN11$25View Abstract
17-Apr-14ValuEngine, Inc.N/AValuEngine Industry Report for OIL & Gas-cdn EXP & Prod17$49View Abstract
17-Apr-14ValuEngine, Inc.N/AValuEngine Industry Report for Medical-biomed/genetics18$49View Abstract
11-Apr-14Reuters Investment ProfileN/ASynthetic Biologics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138View Abstract
11-Apr-14Zacks Investment Research Inc.N/ASYNTHETIC BIOLG (SYN) Zacks Company Snapshot1$11.50View Abstract
11-Apr-14Ford Investor Services, Inc.N/AValue Graph: SYNTHETIC BIOLOG -- SYN1$11.50View Abstract
11-Apr-14Ford Investor Services, Inc.N/AIndustry Value Graph: BONE , MNKD , MDVN , OPK , SYN -- DRUGS3$34.50View Abstract
10-Apr-14Streetwise ReportsKeith MarkeyDon't Miss the Boat on Big Biotech Catalysts: Keith Markey9$92View Abstract
Next 5

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.